BrianEZauggMD

Cataract Related, Cornea & External Disease, Refractive Surgery

Physician

Dr. Zaugg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Utah HealthFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2016
University of Utah HealthResidency, Ophthalmology, 2013 - 2016
University of Utah HealthInternship, Internal Medicine, 2011 - 2012
University of Utah School of MedicineClass of 2011

PubMed

73 citations
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
Asim V Farooq, Simona Degli Esposti, Rakesh Popat, Praneetha Thulasi, Sagar Lonial
Ophthalmology and Therapy. 2020-12-01
43 citations
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Sagar Lonial, Ajay K. Nooka, Praneetha Thulasi, Ashraf Badros, Bennie H. Jeng
Blood Cancer Journal. 2021-05-26
44 citations
Modern Cataract Surgery: Unfinished Business and Unanswered Questions
David J. Apple, Marcela Escobar-Gomez, Brian Zaugg, Guy Kleinmann, Andreas F. Borkenstein
Survey of Ophthalmology. 2011-11-01

Journal Articles

Intraocular Pressure Study Using Monitored Forced-Infusion System Phacoemulsification Technology
Nathan G Lambert, Brian Zaugg, Brian C Stagg, Jeff H Pettey, Tyler Boulter, Jason D Jensen, Randall J Olson, Journal of Cataract & Refractive Surgery